Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US Medical Dialogues Bureau28 Feb 2020 9:12 AM GMTRyaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel fixed-dose combination nasal spray...
Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences Medical Dialogues Bureau8 May 2019 3:45 AM GMTYasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a ...
Glenmark expects generics to drive growth over next 3 yrs Ruby Khatun Khatun25 Sep 2017 5:07 AM GMTMumbai: Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected...
Glenmark looks to file up to 25 product applications annually Ruby Khatun Khatun19 Sep 2017 4:49 AM GMTNew Delhi: Glenmark Pharmaceuticals plans to file close to 25 product applications annually over the next five years, the company's chairman has...
